The domestic pharmaceutical market of Bangladesh reached USD 3.37 billion by the end of Q2 2025, reflecting a 12.4% growth. This sector now contributes approximately 0.72% to the country’s estimated GDP of USD 467 billion.
Top 3 companies by market share (value):
- Square Pharmaceuticals – 17.4%
- Incepta Pharmaceuticals – 12.8% (fastest growth among the top 3, at 20.9%)
- Beximco Pharmaceuticals – 9.6% (steady 12.4% growth, with a 4-year CAGR of 9.1%)
This performance underscores the resilience and competitiveness of Bangladesh’s pharma industry, driven by the strength of local companies in ensuring affordable healthcare and sustainable market growth.
Top 30 Pharmaceuticals Companies in Bangladesh [IQVIA: MAT, Q2 2025]
Read also:
